Merial, the animal health division of Sanofi, has inked a pact with Zoetis India to sell its medicines and vaccines for dairy cattle in India. Merial and Zoetis India Ltd, a subsidiary of Zoetis Inc, have entered into an exclusive marketing and distribution agreement of medicines and vaccines for dairy cattle in India, the companies said in a joint statement.
As part of the deal, Merial will market and sell Zoetis’ products, including brands such as Bovical, Lutalyse, Xnel Dectomax and vaccines like Rispoval and Spirovac. The products will be marketed by Merial India beginning April 2016. “The newly added products complement Merial’s existing ruminant business in India, which includes vaccines, therapeutics and nutritionals,” Country Manager, Merial India, Sandeep Karkhanis said. The pact increases the company’s presence in the important dairy segment and expands its current product offerings, he added.